Logo image of BFK

BLACKROCK MUNICIPAL INC TRST (BFK) Stock Overview

USA - NYSE:BFK - US09248F1093

10.16 USD
+0.11 (+1.09%)
Last: 9/12/2025, 8:04:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BFK. BFK was compared to 0 industry peers in the Unkown industry. BFK has a bad profitability rating. Also its financial health evaluation is rather negative. BFK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BFK was profitable.
BFK had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BFK reported negative net income in multiple years.
BFK had a positive operating cash flow in each of the past 5 years.
BFK Yearly Net Income VS EBIT VS OCF VS FCFBFK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 1.34%
ROE 2.24%
ROIC 2.22%
ROA(3y)-2.72%
ROA(5y)-0.07%
ROE(3y)-4.78%
ROE(5y)-0.39%
ROIC(3y)2.79%
ROIC(5y)2.95%
BFK Yearly ROA, ROE, ROICBFK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

BFK's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of BFK has declined.
BFK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 50%
PM (TTM) 30.56%
GM 52.78%
OM growth 3Y-12.56%
OM growth 5Y-5.31%
PM growth 3Y-51.72%
PM growth 5Y-18.77%
GM growth 3Y-11.39%
GM growth 5Y-4.54%
BFK Yearly Profit, Operating, Gross MarginsBFK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BFK has less shares outstanding
BFK has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BFK has a worse debt to assets ratio.
BFK Yearly Shares OutstandingBFK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
BFK Yearly Total Debt VS Total AssetsBFK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

BFK has an Altman-Z score of 0.56. This is a bad value and indicates that BFK is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.30 indicates that BFK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACCN/A
BFK Yearly LT Debt VS Equity VS FCFBFK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.18 indicates that BFK may have some problems paying its short term obligations.
A Quick Ratio of 0.18 indicates that BFK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
BFK Yearly Current Assets VS Current LiabilitesBFK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 316.67% over the past year.
BFK shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.82% yearly.
The Revenue has been growing slightly by 1.38% in the past year.
Measured over the past years, BFK shows a decrease in Revenue. The Revenue has been decreasing by -4.88% on average per year.
EPS 1Y (TTM)316.67%
EPS 3Y-53.1%
EPS 5Y-21.82%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y-4.71%
Revenue growth 5Y-4.88%
Sales Q2Q%0.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFK Yearly Revenue VS EstimatesBFK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.08, the valuation of BFK can be described as expensive.
The average S&P500 Price/Earnings ratio is at 27.30. BFK is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 39.08
Fwd PE N/A
BFK Price Earnings VS Forward Price EarningsBFK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFK Per share dataBFK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.91%, BFK is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.38, BFK pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.91%

5.2 History

The dividend of BFK decreases each year by -7.54%.
BFK has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BFK decreased recently.
Dividend Growth(5Y)-7.54%
Div Incr Years1
Div Non Decr Years1
BFK Yearly Dividends per shareBFK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

239.64% of the earnings are spent on dividend by BFK. This is not a sustainable payout ratio.
The Dividend Rate of BFK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP239.64%
EPS Next 2YN/A
EPS Next 3YN/A
BFK Yearly Income VS Free CF VS DividendBFK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
BFK Dividend Payout.BFK Dividend Payout, showing the Payout Ratio.BFK Dividend Payout.PayoutRetained Earnings

BLACKROCK MUNICIPAL INC TRST

NYSE:BFK (9/12/2025, 8:04:00 PM)

10.16

+0.11 (+1.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-01 2025-04-01
Earnings (Next)10-01 2025-10-01
Inst Owners39.38%
Inst Owner Change1.57%
Ins OwnersN/A
Ins Owner Change0%
Market Cap445.52M
Analysts0
Price TargetN/A
Short Float %0.33%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 5.91%
Yearly Dividend0.48
Dividend Growth(5Y)-7.54%
DP239.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 39.08
Fwd PE N/A
P/S 12.38
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0.26
EY2.56%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0.82
BVpS11.17
TBVpS11.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.24%
ROCE 2.81%
ROIC 2.22%
ROICexc 2.22%
ROICexgc 2.22%
OM 50%
PM (TTM) 30.56%
GM 52.78%
FCFM N/A
ROA(3y)-2.72%
ROA(5y)-0.07%
ROE(3y)-4.78%
ROE(5y)-0.39%
ROIC(3y)2.79%
ROIC(5y)2.95%
ROICexc(3y)2.79%
ROICexc(5y)2.95%
ROICexgc(3y)2.79%
ROICexgc(5y)2.95%
ROCE(3y)3.53%
ROCE(5y)3.74%
ROICexcg growth 3Y-8.66%
ROICexcg growth 5Y-9.17%
ROICexc growth 3Y-8.66%
ROICexc growth 5Y-9.17%
OM growth 3Y-12.56%
OM growth 5Y-5.31%
PM growth 3Y-51.72%
PM growth 5Y-18.77%
GM growth 3Y-11.39%
GM growth 5Y-4.54%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 0.56
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)316.67%
EPS 3Y-53.1%
EPS 5Y-21.82%
EPS Q2Q%-55.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.38%
Revenue growth 3Y-4.71%
Revenue growth 5Y-4.88%
Sales Q2Q%0.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.66%
EBIT growth 3Y-16.68%
EBIT growth 5Y-9.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.23%
FCF growth 3Y11.03%
FCF growth 5Y-9.77%
OCF growth 1Y-124.4%
OCF growth 3Y11.03%
OCF growth 5Y-9.77%